Skip to main content
. 2022 May 6;8(1):e002031. doi: 10.1136/rmdopen-2021-002031

Figure 2.

Figure 2

Proportion of PSA patients with moderate to high disease activity (DAPSA >14) not receiving a bDMARD in 13 countries, ordered by increasing GDP/capita.